ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Plasma Medicine
SJR: 0.271 SNIP: 0.316 CiteScore™: 1.9

ISSN 印刷: 1947-5764
ISSN オンライン: 1947-5772

Plasma Medicine

DOI: 10.1615/PlasmaMed.2014006273
pages 85-96

Reasons Why We Need Cold Atmospheric Plasmas in Bacteria-Related Diseases in Medicine

Georg Isbary
Department of Dermatology, Allergology, and Environmental Medicine, Hospital Munich, Munich, Germany
Julia Luise Zimmermann
terraplasma GmbH, Garching, Germany; Max-Planck Institute for Extraterrestrial Physics, Garching, Germany
Tetsuji Shimizu
Max Planck Institute for Extraterrestrial Physics, Garching, Germany
Gregor Ego Morfill
Max Planck Institute for extraterrestrial Physics, Giessenbachstrasse, D-85471 Garching, Germany
Anindita Mitra
Max Planck Institute for Extraterrestrial Physics, Garching, Germany
Hubertus Maria Thomas
Max Planck Institute for Extraterrestrial Physics, Garching, Germany
Tobias Gabriel Klampfl
Max Planck Institute for Extraterrestrial Physics, Garching, Germany; Department of Pathology, Technical University of Munich, Munich, Germany
Julia Koeritzer
Max Planck Institute for Extraterrestrial Physics, Garching, Germany; Department of Pathology, Technical University of Munich, Munich, Germany
Veronika Boxhammer
Max Planck Institute for Extraterrestrial Physics, Garching, Germany; Department of Pathology, Technical University of Munich, Munich, Germany
Jurgen Schlegel
Department of Pathology, Technical University of Munich, Munich, Germany
Wilhelm Stolz
Department of Dermatology, Allergology, and Environmental Medicine, Hospital Munich, Munich, Germany

要約

Upcoming technologies for medical purposes must demonstrate their unique features and benefits compared with other methods in use. Cold atmospheric plasma technology has unique properties regarding antimicrobial purposes, owing to the numerous ways to generate and design the plasma. To date, no primary resistance against any tested microbes has been found. Furthermore, several tests and theoretical calculations show the unlikelihood of microbes acquiring resistance against cold atmospheric plasma. The latter fact is the main advantage of cold atmospheric plasma technology compared with conventional antimicrobial products (e.g., antibiotics) available in the medical sector, whose more or less uncontrolled usage has led to global resistance concerns and possibly to a lack of future treatment approaches.


Articles with similar content:

Review of Anti-Bacterial Activities of Curcumin against Pseudomonas aeruginosa
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 5
Hamid Reza Rahimi, Zohreh Neyestani, Anahita Ghazaghi, Seyed Ali Ebrahimi, Amin Jalili, Amirhossein Sahebkar
Photosensitized Inactivation of Protozoa Pathogenic Agents of Water- and Vector-Borne Diseases
Onco Therapeutics, Vol.2, 2011, issue 3
Laura Guidolin, Clara Fabris, Marina Soncin, Giulio Jori, Olimpia Coppellotti
Mushrooms in Medicine and Culture
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 1&2
Edgar J. DaSilva
An Overview of Culinary and Medicinal Mushrooms in Neurodegeneration and Neurotrauma Research
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 3
Chai-Chee Ng, Kah-Hui Wong, Gowri Kanagasabapathy, Yoon-Yen Yow, Vikineswary Sabaratnam
The Sterilization Technology Research on the Non-thermal Atmospheric Plasma
Plasma Medicine, Vol.2, 2012, issue 4
Chao Wang, Harm Tolner, B. Li, Guozhou Rao, Huina Zhao, Tao Jiang, Ang Li